■小儿肾病综合征患者的运动疗法对于改善患者的身体功能是必要的,以维持患者的日常生活和学校生活活动,同时控制复发的风险;然而,很少有研究检查该综合征急性期的运动疗法。本案例研究旨在评估运动疗法在接受类固醇治疗的急性小儿肾病综合征患者中的疗效和安全性。
患者是一名10岁男孩,被诊断为原发性肾病综合征。泼尼松龙(50mg)在住院的第3天开始。运动疗法(中等强度,40分钟,每周五次)在第15天开始。从第15天(康复开始)到出院的尿蛋白/肌酐比从1.1降至0.4,没有肾病综合征复发。在最初,中间,和最终评估,分别,握力为10.1、8.9和8.3kg;膝盖伸展力量为0.38、0.46和0.45kgf/kg;仰卧起坐测试结果为18、18和15次;侧步测试结果为34、36和31次;坐姿测试结果为22.9、24.5和23.8cm;6分钟步行测试结果为肌肉力量420和运动能力520m。但上肢力量,躯干肌肉力量,敏捷性下降。
■对于急性期肾病综合征的儿科患者,中等强度的锻炼可能是有效和安全的。运动疗法可能有益于改善小儿肾病综合征患者的身体功能并防止住院期间的下降。
UNASSIGNED: Exercise therapy for patients with pediatric nephrotic syndrome is necessary to improve physical function to maintain the patient\'s activities of daily life and school life while managing the risk of relapse; however, few studies have examined exercise therapy in the acute phase of the syndrome. This
case study aimed to evaluate the efficacy and safety of exercise therapy in a patient with acute pediatric nephrotic syndrome being treated with steroids.
UNASSIGNED: The patient was a 10-year-old boy diagnosed with primary nephrotic syndrome. Prednisolone (50 mg) was started on the 3rd day of hospitalization. Exercise therapy (moderate-intensity, 40 min, five times a week) was started on the 15th day. The urine protein/creatinine ratio from the 15th day (at the start of rehabilitation) to discharge decreased from 1.1 to 0.4, with no recurrence of nephrotic syndrome. At the initial, middle, and final evaluations, respectively, the grip strength was 10.1, 8.9, and 8.3 kg; the knee extension strength was 0.38, 0.46, and 0.45 kgf/kg; the sit-up test results were 18, 18, and 15 times; the side-step test results were 34, 36, and 31 times; the sit-and-reach test results were 22.9, 24.5, and 23.8 cm; and the 6-min walk test results were 420, 490, and 520 m. Leg muscle strength and exercise tolerance improved, but upper limb strength, trunk muscle strength, and agility decreased.
UNASSIGNED: Moderate-intensity exercises may be effective and safe for pediatric patients with nephrotic syndrome in the acute phase. Exercise therapy may be beneficial to improve physical function and prevent decline during hospitalization in pediatric nephrotic syndrome patients.